Diagnostics News and Research

RSS

Bruker to acquire Center for Tribology

Bruker Corporation today announced the signing of a purchase agreement to acquire Center for Tribology, Inc. (CETR) for an undisclosed amount.

12 Sep 2011

IBN scientists harness ultrasmall peptides to repair spinal disc damage

New ultrasmall peptides that can be used as building blocks for a wide range of regenerative applications such as spinal disc replacement and cartilage repair have been developed by scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute. These peptides spontaneously assemble in water to form hydrogels, which resemble collagen, a major component of connective tissues found in cartilage, ligaments, tendons, bone and skin.

12 Sep 2011

ASTMH annual meeting to explore latest research on infectious diseases

The 60th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) -- the largest of its kind in the world -- will bring together in one place global experts who are battling a wide range of bacteria, viruses, parasites and other pathogens that each year kill or sicken hundreds of millions of people.

12 Sep 2011

Roche initiates Phase 1 clinical trial of investigational drug for Down syndrome

Roche today announced the initiation of its first Phase 1 clinical trial to investigate the safety and tolerability of a molecule designed to address the cognitive and behavioral deficits associated with Down syndrome.

12 Sep 2011

Landmark discovery in rapid spread of PRL-3 oncoprotein associated aggressive cancers

Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have made a landmark discovery in the battle against the rapid spread of aggressive cancers associated with PRL-3 oncoprotein.

9 Sep 2011

Quest Diagnostics placed on Dow Jones Sustainability Indexes

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones® Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America).

From Quest Diagnostics 9 Sep 2011

Japan's CCRC to implement Medidata Rave's EDC/CDM system

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that the Chiba University Hospital Clinical Research Center, one of Japan's leading clinical research institutions, has chosen Medidata Rave as its electronic data capture (EDC) and clinical data management (CDM) solution.

8 Sep 2011

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Pall Corporation, a global leader in filtration, separation and purification, today inaugurated its Pall Life Sciences Centre of Excellence in Singapore, the latest addition to the company's global customer support network.

From Pall Corporation 8 Sep 2011

Scientists invent new system that uses magnetism to purify hybrid nanoparticles

A team of Penn State University scientists has invented a new system that uses magnetism to purify hybrid nanoparticles -- structures that are composed of two or more kinds of materials in an extremely small particle that is visible only with an electron microscope.

8 Sep 2011

GE Healthcare granted exclusive distribution rights to KC BioMedix NTrainer neurostimulation system

GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.

8 Sep 2011

NJIT to honor electrical engineer for nanotechnology research

What do brilliantly colored glass, advanced batteries, and innovative technology for the regulation of brain functions have in common? They are nano-scale structures far smaller than the wavelengths of energy coursing through them in different regions of the electromagnetic spectrum, said NJIT Professor Haim Grebel.

8 Sep 2011

Thermo Fisher Scientific offers siRNA libraries in Labcyte Echo qualified source plates

Labcyte Inc., a leader in miniaturization technologies for liquid handling, announced today that Thermo Fisher Scientific, the world leader in serving science, is offering the option for customers to receive siRNA (small-interfering RNA) reagent libraries in Labcyte Echo qualified source plates.

From Thermo Fisher Scientific Inc. 7 Sep 2011

Combination of blood tests and ROMA algorithm receives FDA clearance to treat ovarian cancer

Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.

7 Sep 2011

Use of nonaspirin NSAIDs during early pregnancy raises risk of miscarriage in women

The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy, according to a University of Montreal study in CMAJ.

7 Sep 2011

SYSU, ASU collaborate to develop early and predictive diagnostics for colorectal cancer

Arizona State University (ASU) and China's Sun Yat-Sen University (SYSU) have formalized a research collaboration aimed at developing early and predictive diagnostics to improve patient outcomes for colorectal cancer.

7 Sep 2011

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

7 Sep 2011

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today it will move its research and development operations from Cincinnati to its headquarters in Hubbard, Ohio.

6 Sep 2011

European Neurotech Investing & Partnering Summit to take place in Helsinki

The inaugural European Neurotech Investing & Partnering Summit takes place in Helsinki this week. It features keynotes on the state of the European neurotech industry, investor analysis, as well as company and research project presentations on next generation treatments emerging in the EU for unmet needs of brain and nervous system disorders like Alzheimer's, addiction, depression, schizophrenia, Parkinson's, Huntington's, stroke and more.

6 Sep 2011

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

QIAGEN today announced that it has entered into a partnership with Eli Lilly and Company for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly. Financial terms of the agreement were not disclosed.

From QIAGEN Manchester Limited 6 Sep 2011

Roche Diagnostics terminates sales and distribution agreement with Response

Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.

From Roche Sequencing and Life Science 2 Sep 2011

Diagnostics News and Research

Bruker to acquire Center for Tribology

IBN scientists harness ultrasmall peptides to repair spinal disc damage

ASTMH annual meeting to explore latest research on infectious diseases

Roche initiates Phase 1 clinical trial of investigational drug for Down syndrome

Landmark discovery in rapid spread of PRL-3 oncoprotein associated aggressive cancers

Quest Diagnostics placed on Dow Jones Sustainability Indexes

Japan's CCRC to implement Medidata Rave's EDC/CDM system

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Scientists invent new system that uses magnetism to purify hybrid nanoparticles

GE Healthcare granted exclusive distribution rights to KC BioMedix NTrainer neurostimulation system

NJIT to honor electrical engineer for nanotechnology research

Thermo Fisher Scientific offers siRNA libraries in Labcyte Echo qualified source plates

Combination of blood tests and ROMA algorithm receives FDA clearance to treat ovarian cancer

Use of nonaspirin NSAIDs during early pregnancy raises risk of miscarriage in women

SYSU, ASU collaborate to develop early and predictive diagnostics for colorectal cancer

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

European Neurotech Investing & Partnering Summit to take place in Helsinki

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Roche Diagnostics terminates sales and distribution agreement with Response

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News